Profile
Lars Nieba currently works at Engimmune Therapeutics AG, as Chief Executive Officer & Director from 2023.
Dr. Nieba also formerly worked at Bayer AG, as Vice President from 2016 to 2019, Nordic Nanovector ASA, as Chief Executive & Technology Officer from 2020 to 2021, and Pureos Partners AG, as Venture Partner from 2021 to 2023.
Dr. Nieba received his graduate degree in 1993 from the University of Freiburg, Masters Business Admin degree in 2003 from the University of St. Gallen, and doctorate degree in 1997 from the University of Zurich.
Lars Nieba active positions
| Companies | Position | Start |
|---|---|---|
Engimmune Therapeutics AG
Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers | Chief Executive Officer | 19/04/2023 |
Former positions of Lars Nieba
| Companies | Position | End |
|---|---|---|
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions. | Private Equity Investor | 30/04/2023 |
| BAYER AG | Corporate Officer/Principal | 01/11/2019 |
| THOR MEDICAL | Chief Executive Officer | 06/04/2021 |
Training of Lars Nieba
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions. | Finance |
Engimmune Therapeutics AG
Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers | Health Technology |
- Stock Market
- Insiders
- Lars Nieba
















